SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-000699
Filing Date
2024-01-05
Accepted
2024-01-05 17:34:07
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1704494031.html 4  
1 FORM 4 wk-form4_1704494031.xml 4 3353
  Complete submission text file 0001628280-24-000699.txt   4796
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MIRATI THERAPEUTICS, INC. 9393 TOWNE CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Christensen Jamie (Reporting) CIK: 0001599324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 24517657